Shares Of Halozyme Up 14% Following FDA Removal Of Hold On PEGPH20 By: Benzinga via Benzinga June 05, 2014 at 11:29 AM EDT Shares of Halozyme Therapeutics (NASDAQ: HALO) at one point spiked more than 20 percent following the U.S. Food and Drug ... Read More >> Related Stocks: Halozyme Therapeutic